Institute for Biotechnology and Bioengineering

Institute for Biotechnology and Bioengineering

Open Access statistics for Institute for Biotechnology and Bioengineering, Portugal, covering academic research published from 2000 to 2023.

Open Access statistics for Institute for Biotechnology and Bioengineering, Portugal, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

60%


Total
Publications

3.9K


Total Open
Publications

2.4K


Total
Citations

167K


Open Access
Percentage

60%


Total
Publications

3.9K


Total Open
Publications

2.4K


Total
Citations

167K

Website

download

Breakdown

7% 24% 30% 39%

Publisher Open

7%

Both

24%

Other Platform Open

30%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300350400Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

51%OA Journal

OA Journal 51%

611

Hybrid 23%

282

No Guarantees 26%

315

Other Platform Open

Institution 76%

1.6K

Domain 38%

796

Public 10%

198

Other Internet 7%

145

Preprint 3%

54

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
793
Universidade do Minho - RepositóriUM
Institution
630
RCAAP Project by FCT - Portuguese National Funding Agency for Science, Research and Technology - RCAAP Search Portal
Institution
609
Europe PMC
Domain
526
Semantic Scholar
Public
180
RCAAP Project by FCT - Portuguese National Funding Agency for Science, Research and Technology - RCAAP Search Portal
Other Internet
117
CiteSeer X
Other Internet
41
Algarve University - Sapientia
Institution
31
ualg.pt OAI-PMH Repository
Institution
28
Le Centre pour la Communication Scientifique Directe - HAL - Archive ouverte HAL
Institution
28
1 / 20

Data updated 17 June 2024

Share

Share

Share